Maria Russeva

Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro

Matthew K. Robinson, Kathryn M. Hodge, Eva Horak et al. · British Journal of Cancer · 2008 · 130 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

Isolation of scFvs to <i>In Vitro</i> Produced Extracellular Domains of EGFR Family Members

Eva Horak, Tara Heitner, Matthew K. Robinson et al. · Cancer Biotherapy and Radiopharmaceuticals · 2005 · 34 citations

Pharmacy, Molecular Biology, Oncology +17

Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer

Qing‐An Yuan, Heidi H. Simmons, Matthew K. Robinson et al. · Molecular Cancer Therapeutics · 2006 · 25 citations

Pharmacy, Cancer Biology, Oncology +17

Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning

Qing‐An Yuan, Matthew K. Robinson, Heidi H. Simmons et al. · Cancer Immunology Immunotherapy · 2007 · 19 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +9

Tpl‐2 induces apoptosis by promoting the assembly of protein complexes that contain caspase‐9, the adapter protein Tvl‐1, and procaspase‐3

Christos Patriotis, Maria Russeva, Jun‐Hsiang Lin et al. · Journal of Cellular Physiology · 2001 · 15 citations

Life Sciences, Molecular Biology, Oncology +17